These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 9058107)

  • 41. Unilateral limited scleroderma-like changes following formation of an arteriovenous fistula.
    Roberts H; Curnow PA
    Australas J Dermatol; 2007 Feb; 48(1):37-9. PubMed ID: 17222301
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Letter: Raynaud's disease and systemic sclerosis.
    Rowell NR
    Br Med J; 1973 Nov; 4(5890):493. PubMed ID: 4758478
    [No Abstract]   [Full Text] [Related]  

  • 43. Efficacy of nifedipine in Raynaud's phenomenon associated with systemic sclerosis.
    Thakur SK; Gopinathan VP; Jagdish TK; Bhalla IP; Shetty KJ
    J Assoc Physicians India; 1986 Jul; 34(7):536. PubMed ID: 3759897
    [No Abstract]   [Full Text] [Related]  

  • 44. CRST syndrome with persistent gastrointestinal bleeding. (Calcinosis, raynaud's phenomenon, sclerodactyly and telangiectasia).
    Kolodny M; Baker WG
    Gastrointest Endosc; 1968 Aug; 15(1):16-7. PubMed ID: 5302707
    [No Abstract]   [Full Text] [Related]  

  • 45. [Heart lesions in progressive systemic sclerosis. Intramyocardial Raynaud's phenomenon].
    Frandsen NE
    Ugeskr Laeger; 1980 May; 142(22):1423-4. PubMed ID: 7404748
    [No Abstract]   [Full Text] [Related]  

  • 46. Coexistence of diabetes mellitus type 1 with diffuse systemic sclerosis - case report and literature review.
    Wielosz E; Kurowska M; Suszek D; Majdan M
    Reumatologia; 2017; 55(2):104-107. PubMed ID: 28539684
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prevalence and evolution of scleroderma pattern at nailfold videocapillaroscopy in systemic sclerosis patients: Clinical and prognostic implications.
    Ghizzoni C; Sebastiani M; Manfredi A; Campomori F; Colaci M; Giuggioli D; Ferri C
    Microvasc Res; 2015 May; 99():92-5. PubMed ID: 25842153
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Plasma adrenomedullin and endothelin-1 levels are reduced and Raynaud's phenomenon improved by daily tadalafil administration in male patients with systemic sclerosis.
    Rosato E; Letizia C; Proietti M; Aversa A; Menghi G; Rossi C; Torella E; Cotesta D; Petramala L; Bruzziches R; Spera G; Pisarri S; Salsano F
    J Biol Regul Homeost Agents; 2009; 23(1):23-9. PubMed ID: 19321043
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Esophageal motility in Raynaud's disease, systemic scleroderma and presclerodermal Raynaud's syndrome].
    Hostein J; Bost R; Carpentier P; Franco A; Fournet J
    Gastroenterol Clin Biol; 1985 Feb; 9(2):130-5. PubMed ID: 3979734
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Scleroderma and primary biliary cirrhosis.
    Murray-Lyon IM; Thompson RP; Ansell ID; Williams R
    Br Med J; 1970 Aug; 3(5717):258-9. PubMed ID: 5448799
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cutaneous Manifestations of Scleroderma and Scleroderma-Like Disorders: a Comprehensive Review.
    Ferreli C; Gasparini G; Parodi A; Cozzani E; Rongioletti F; Atzori L
    Clin Rev Allergy Immunol; 2017 Dec; 53(3):306-336. PubMed ID: 28712039
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Raynaud's phenomenon and systemic sclerosis.
    Generini S; Kahaleh B; Matucci-Cerinic M; Pignone A; Lombardi A; Ohtsuka T
    Ann Ital Med Int; 1996; 11(2):125-31. PubMed ID: 8974438
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Raynaud's phenomenon and scleroderma; a case report and psychodynamic formulation.
    RICHARDSON HB
    Psychoanal Rev; 1955 Jan; 42(1):24-38. PubMed ID: 14371880
    [No Abstract]   [Full Text] [Related]  

  • 54. [Calcinosis, Raynaud's phenomenom, sclerodactylia and telangiectasia in progressive systemic sclerosis. Statistical analysis of contingencies].
    Mintz G
    Gac Med Mex; 1976 Jun; 107(6):525-36. PubMed ID: 976673
    [No Abstract]   [Full Text] [Related]  

  • 55. Raynaud phenomenon and the vascular disease in scleroderma.
    Kahaleh MB
    Curr Opin Rheumatol; 2004 Nov; 16(6):718-22. PubMed ID: 15577610
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Use of defibrotide in the treatment of Raynaud's phenomenon associated with progressive systemic sclerosis or essential mixed cryoglobulinemia].
    Ranieri G; De Mitrio V; Petronelli M; Ancona A; Dammacco F
    Clin Ter; 1988 Sep; 126(5):335-43. PubMed ID: 2973963
    [No Abstract]   [Full Text] [Related]  

  • 57. [Raynaud's phenomenon and scleroderma (author's transl)].
    Merlen JF
    Ann Cardiol Angeiol (Paris); 1980 Jun; 29(4):333-7. PubMed ID: 7447353
    [No Abstract]   [Full Text] [Related]  

  • 58. [Perioperative management of a patient with transient polyuria].
    Fukuda T; Okutani R; Kono K; Ishida H
    Masui; 1992 Aug; 41(8):1305-10. PubMed ID: 1433856
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bilateral aseptic necrosis of the lunate in systemic sclerosis.
    Agus B
    Clin Exp Rheumatol; 1987; 5(2):155-7. PubMed ID: 3608271
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Systemic sclerosis - a rare but important diagnosis in primary health care].
    Andreasson K; Lillpers K; Wollheim F; Hesselstrand R
    Lakartidningen; 2019 Sep; 116():. PubMed ID: 31573670
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.